REDUCED TET2 FUNCTION CONTRIBUTES TO DEVELOPMENT OF PERIPHERAL T-CELL LYMPHOMA THROUGH IMPAIRMENT OF EPIGENETIC REGULATION

被引：0
|
作者：
Sakata-Yanagimoto, M. [1 ]
Muto, H. [1 ]
Nagae, G. [2 ]
Miyake, Y. [1 ]
Enami, T. [1 ]
Kamada, Y. [1 ]
Kato, T. [1 ]
Nishikii, H. [1 ]
Suzukawa, K. [1 ]
Nakamura, N. [3 ]
Aburatani, H. [2 ]
Ogawa, S. [4 ]
Chiba, S. [1 ]
机构：
[1] Univ Tsukuba, Dept Hematol, Ibaraki, Japan
[2] Univ Tokyo, Genome Sci Div, RCAST, Tokyo, Japan
[3] Tokai Univ, Dept Pathol, Sch Med, Hiratsuka, Kanagawa, Japan
[4] Univ Tokyo, Canc Genom Project, Tokyo, Japan
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S1118
引用
收藏
页码：460 / 460
页数：1
相关论文
共 50 条
  • [21] Double somatic mosaic mutations in TET2 and DNMT3A-origin of peripheral T cell lymphoma in a case
    Nguyen, Tran B.
    Sakata-Yanagimoto, Mamiko
    Nakamoto-Matsubara, Rie
    Enami, Terukazu
    Ito, Yufu
    Kobayashi, Toshikata
    Obara, Naoshi
    Hasegawa, Yuichi
    Chiba, Shigeru
    ANNALS OF HEMATOLOGY, 2015, 94 (07) : 1221 - 1223
  • [22] Double somatic mosaic mutations in TET2 and DNMT3A—origin of peripheral T cell lymphoma in a case
    Tran B. Nguyen
    Mamiko Sakata-Yanagimoto
    Rie Nakamoto-Matsubara
    Terukazu Enami
    Yufu Ito
    Toshikata Kobayashi
    Naoshi Obara
    Yuichi Hasegawa
    Shigeru Chiba
    Annals of Hematology, 2015, 94 : 1221 - 1223
  • [23] Loss of Ripk3 signaling promotes T cell lymphoma development in Tet2 deficient mice
    Joshi, Kanak
    Zinzuwadia, Shuchi
    Mack, Ryan
    Zhang, Lei
    Liu, Shanhui
    Sellin, Mark
    Wei, Wei
    Breslin, Peter
    Kini, Ameet R.
    Zhang, Jiwang
    CANCER RESEARCH, 2022, 82 (12)
  • [24] Efficacy of 5-Azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma
    Cheminant, Morgane
    Bruneau, Julie
    Kosmider, Olivier
    Lefrere, Francois
    Delarue, Richard
    Gaulard, Philippe
    Radford, Isabelle
    Derrieux, Coralie
    Hermine, Olivier
    Lemonnier, Francois
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (06) : 913 - 916
  • [25] Novel Agents in Development for Peripheral T-Cell Lymphoma
    O'Connor, Owen A.
    SEMINARS IN HEMATOLOGY, 2010, 47 (02) : S11 - S14
  • [26] Development of new agents for peripheral T-cell lymphoma
    Ito, Yuta
    Makita, Shinichi
    Tobinai, Kensei
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (03) : 197 - 209
  • [27] Development of Masitinib for the Treatment of Peripheral T-Cell Lymphoma
    Hermine, Olivier
    Marcais, Ambroise
    Maciel, Thiago
    Bagbor, J.
    Jagielski, Darius
    Holtermann, Nadine
    Martinez de Merlo, Elena
    Thamm, Douglas H.
    Dubreuil, Patrice
    Moussy, Alain
    BLOOD, 2015, 126 (23)
  • [28] Role of methionine on epigenetic regulation in Adult T-cell leukemia/ lymphoma
    Watanabe, Tatsuro
    Ureshino, Hiroshi
    Nakamura, Hideaki
    Sueoka, Eisaburo
    Kimura, Shinya
    CANCER SCIENCE, 2022, 113 : 373 - 373
  • [29] Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia
    De Coninck, Stien
    Roels, Juliette
    Lintermans, Beatrice
    T'Sas, Sara
    Taghon, Tom
    Curtis, David J.
    Pieters, Tim
    Goossens, Steven
    Van Vlierberghe, Pieter
    BLOOD ADVANCES, 2024, 8 (11) : 2646 - 2649
  • [30] Notch signalling in the regulation of peripheral T-cell function
    Mckenzie, GJ
    Young, LL
    Briend, E
    Lamb, JR
    Dallman, MJ
    Champion, BR
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2003, 14 (02) : 127 - 134
12345